We are a Swedish medical engineering company with ten years of research and development, supported by world-renowned medical expertise and specialist engineers.
We started with extracorporeal dialysis solution regeneration in 2005 and continued with extracorporeal heart failure treatment in 2013. Our goal is to develop medical devices for wearable ultrafiltration and dialysis. Patient safety is fundamental and our highest priority.
Every day we work with the implementation of carefully controlled product development processes within and around Triomed and its products.
We value our external partners and work in close cooperation with them. All medical staff and patients will be trained in the correct way of using our products.
For top production performance and distribution of Triomed’s specifications, we follow the laws and regulations applicable to the field of industry to ensure compliance with MDD 93/42/EEC and applicable ISO standards.
Member of the Board of Directors since 2012. Born 1945. Ugo Grondelli is a Master of Science in Business and Economics with an MBA from UCLA (University of California). He has 40 years’ experience of corporate management and board work within medical technology and healthcare services. Grondelli leads his own company, Spindial Europé S. A., based in Luxembourg, which operates as a product supplier mainly to the dialysis and intensive care market but also runs their own clinics. Grondelli is a member of the board of Alteco AB in Lund, a medical technology company. Previous experience includes Executive Vice President within the Gambro group, Chairman of the Board of Hospal AG, Switzerland, Vice President of Jostra AG, Germany, and board member of Q-Med AB.
Holding in Triomed: 243 shares
Member of the Board of Directors since 2012. Born 1953. Co-founder of Triomed. Since the beginning of the 1990s, Anders Helmner has successfully driven the development, production and distribution of components for medium-haul commercial aircraft. He has also built up the global distribution of components for long-haul commercial aircraft.
Holding in Triomed: 1175 shares
Member of the Board of Directors since 2012. Born 1955. Lars Persson represents Sydsvensk Entreprenörsfond. He has long experience from leading positions in MedTech and Venture Capital industries. Previously, Lars Persson worked at Industrifonden and Atos Medical AB. He also has experience as chairman and board member in a number of medical technology companies.
Holding in Triomed: 0 shares
Chairman of the Board since 2016. Born 1954.
Current assignments: Executive Chairman of KMG Capital Partners, LLC and Chairman of Surefire Medical, Inc. Board member and independent lead director of Coherus Biosciences Inc, Board member of Alteco Medical AB,PCI HealthDey, LLC and Empirican Group, Inc.
Previous assignments: More than 30 years of international experience in health care from such positions as CFO and Executive Vice President of the Gambro Group and as CEO of Gambro Healthcare Inc. He has also served as Co-CEO of Fresenius Medical Care North America, CEO of Fresenius Medical Services, and was a member of the Management Board for Fresenius Medical Care AG & Co. KGaA.
Holding in Triomed: 60 shares
Member of the Board of Directors since 2012. Born 1955. Co-founder of Triomed. Lars Wramner is a Doctor of Medicine and has been the chief physician of transplant surgery at Sahlgrenska University Hospital. He has long experience of kidney transplants and access surgery for dialysis treatment and has worked in close cooperation with the Nephrology clinic. Works as Medical Director in Triomed.
Holding in Triomed: 513 shares
Ulf Öjerklint is a lawyer and senior partner at Gärde Wesslau law firm and has been practising business law since 1984. Ulf Öjerklint has conducted a large number of transactions comprising extensive commercial agreements combined with establishment of various legal structures. In addition, Ulf Öjerklint has assisted numerous clients in structured procedures regarding sales and acquisitions of companies as well as financial assignments in order to generate funds on the venture capital market. Ulf Öjerklint is active in a number of corporate boards.
Holding in Triomed: 0 shares
Member of the Board of Directors since 2016. Born 1954. Co-founder of Triomed. Anders Wallenås is a Master of Science in Engineering, Mechanical Engineering and has more than 30 years’ experience of running industrial development projects. He has been operative in various industries with the development of products all the way from the early stages to a commercial product. Anders Wallenås is a board member of Avena Energi AB in Lund.
Holding in Triomed: 531 shares
Member of the Board of Directors since 2016. Dr Bosch is a Nephrologist with extensive experience in Clinical Medicine, Neprology and research in Artificial Organs.He has written over 100 papers in the field. Has has occupied Academic positions in USA Medical Schools and reached the Title of Professor withTenure at George Washington University in Washington DC.
Patrick Greatrex has been the CEO of Triomed since September 2016. Prior to joining Triomed Patrick had a number of CEO and senior management roles in life science companies including CEO of Vivoline Medical AB and Vice President of Business Development at Gambro AB. Patrick has been awarded Bachelor Degrees in Law and Arts from the University of Queensland and an MBA from Lund University.
Anders Wallenås, MSc
Chief Scientific and Research Officer
Anders Wallenås joined Triomed AB 2005. Anders Wallenås has a Master of Science in Engineering and Mechanical Engineering with more than 30 years’ experience of running industrial development projects. He has been operative in various industries with the development of products all the way from the early stages to a commercial product.
Nina Meinander, PhD
R&D Chemistry Manager
Nina Meinander joined Triomed AB in 2012 as Manager of the Chemistry R&D Team, and leads the development of adsorbent devices for purification of dialysis fluid. Nina Meinander has 13 years’ experience from pharmaceutical R&D, and has an MSc in Chemical Engineering and a PhD in Applied Microbiology/Biotechnology.
Hans Bengtsson, MSc
R&D Product Development Manager
Hans Bengtsson joined Triomed AB in 2012 as Manager of the Mechanics and Electronics R&D team, and leads the development of Triomed products. Hans Bengtsson has an MSc in Mechanical Engineering and more than 20 years’ experience of leading R&D projects.
Lars Wramner MD, PhD
Lars Wramner joined Triomed in 2012 and as Medical Director is responsible for the medical department at Triomed. A Doctor of Medicine, he was the chief physician of transplant surgery at Sahlgrenska University Hospital. With long experience of kidney transplants and access surgery for dialysis treatment, he works in close cooperation with the Nephrology clinic.
Anita Fjaestad joined Triomed AB in 2016 and has worked more than 20 years in the international life science industry within the field of Quality and Regulatory at Elekta AB in Stockholm and Gambro (now Baxter) in Lund. Anita has a MSc in Mechanical Engineering.
Dr R Dell’Aquila
Dr Dell’Aquila is Associate Professor of Nephrology and Medical Director of Nephrology at the dialysis clinic in Bassano del Grappa’s hospital in Italy. He is a leading expert on PD treatment and has published around 60 scientific articles.
Dr M Feriano
Dr Feriano is Associate Professor of Nephrology and Medical Director of Nephrology at the dialysis clinic in Mestre-Venice Hospital, Venice, Italy. He is a leading expert on PD treatment and has published around 90 scientific articles.
Dr A-C Johansson
Dr Johansson is the chief physician and head of the division for peritoneal dialysis at Skåne University Hospital in Malmö. She is Associate Professor of Nephrology and a leading Swedish expert on PD treatment. Dr. Johansson has published around 10 scientific articles.
Professor V Schwenger
Professor Schwenger is Professor of Nephrology at Heidelberg University. Previously chief physician in Nephrology at Heidelberg University Hospital. Professor Schwenger is head of the Nephrology clinic in Stuttgart. He is the leading expert on peritoneal dialysis in Germany and hosts an annual congress in Heidelberg with over 700 German nephrologists. He is also an advisor to the German government on renal issues. He has published around 100 scientific articles.
It is of utmost importance to us at Triomed that all employees work in a safe and healthy work environment. We are continuously improving internal procedures to ensure staff well-being.
We are certified under the ISO 13485:2012 for the design, development, production, service, sales and distribution of active and non-active medical devices for the ultrafiltration of congestive heart failure patients with fluid overload.
Certification ISO 13485:2012 requires a thorough review of the company’s internal quality management system processes by an accredited third-party auditing organization to ensure the company is capable of consistently delivering products and services that meet both customer needs and expectations and regulatory requirements for the industry. Our quality management system has been registered by TÜV SÜD Product Service GmbH, one of the world’s leading providers of management system certification, recognized for their expert auditors and thorough assessments.
As an organization we take pride in ensuring customer satisfaction by providing medical devices that fulfil our customer needs. Receiving this certification emphasizes our commitment to quality throughout our business.
Quality of Life – inside and out